Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
Marco Colleoni(European Institute of Oncology), Joanna Vermeij(Ziekenhuisnetwerk Antwerpen Stuivenberg), Patrick Neven(KU Leuven), Jeroen Mebis(Jessa Hospital), Meredith M. Regan(Dana-Farber Cancer Institute), Séamus O’Reilly(Royal College of Surgeons in Ireland), C. Mitine, Bettina Müller, Didier Verhoeven, Lionel Duck, Alastair M. Thompson(Baylor College of Medicine), Edda Simoncini(International Breast Cancer Study Group), Christian Marth(Nordic Society of Gynecologic Oncology), Peter Vuylsteke(Champalimaud Foundation), Philippe Glorieux, Richard D. Gelber(Harvard University), Katsumasa Kuroi, Stefan Aebi(University of Lucerne), Michael Coibion, Rudolf Maibach(The Coordinating Center), Martine Berlière(Cliniques Universitaires Saint-Luc), Harold J. Burstein(Dana-Farber Cancer Institute), Marie-Pascale Graas(Centre Hospitalier Chrétien), Annelore Barbeaux, A. Vandebroek, Manuela Rabaglio(University Hospital of Bern), Patrick Berteloot(KU Leuven), Guy Jérusalem(Centre Hospitalier Universitaire de Liège), Alan S. Coates(International Breast Cancer Study Group), Jacquie Chirgwin(Uppsala University Hospital), Jean-Paul Salmon, Claus Kamby(University of Copenhagen), Erika Hitre(National Institute of Oncology), Sibylle Loibl(Goethe University Frankfurt), Giuseppe Viale(University of Milan), Per Karlsson(University of Gothenburg), Wim Wyendaele, Vincenzo Di Lauro(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Weixiu Luo(Dana-Farber Cancer Institute), Angelo Di Leo(Hospital of Prato), Andrea Gombos(Institut Jules Bordet), Frédéric Forget, Marleen Borms, Randal D’hondt, Jürg Bernhard(International Breast Cancer Study Group), Aron Goldhirsch(Istituti di Ricovero e Cura a Carattere Scientifico), Karin Ribi, Joaquín Gavilá(Fundación Instituto Valenciano de Oncología), Thomas Ruhstaller(University Hospital Bonn)
Cited by 122
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
|Annals of Oncology|2013|3.7k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k